Psyence Biomedical (PBM) vs Rocket One (RKTO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Rocket One (RKTO) has outperformed Psyence Biomedical (PBM) over the past year, losing 61.1% versus a loss of 96.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PBM | RKTO |
|---|---|---|
| Share price | $4.97 | $0.6493 |
| Market cap | — | $16.17M |
| 1-day change | -2.93% | +0.50% |
| YTD return | -83.10% | -34.41% |
| 1-year return | -96.56% | -61.12% |
| 5-year return | — | -97.76% |
| EPS (TTM) | $-12.56 | $-0.82 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $150.78 | $2.45 |
| 52-week low | $1.92 | $0.489 |
| Distance from 52-week high | -96.70% | -73.50% |
| Average volume | 94.85K | 554.01K |
| Shares outstanding | — | 24.90M |
| Employees | 12 | 2 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- RKTO has outperformed PBM by 35.4 percentage points over the past year.
About Psyence Biomedical
PBM stock →Psyence Biomedical Ltd., an integrated biopharmaceutical company, focuses on the development of botanical psilocybin-based psychedelic medicines. Its lead product candidate is NPX-5, a botanical drug candidate that is in Phase IIb clinical study for the treatment of adjustment disorder in patients with cancer in a palliative care setting.
Health Care · Biotechnology: Pharmaceutical Preparations · 12 employees
About Rocket One
RKTO stock →Rocket One Inc. focuses on developing and commercializing AI semiconductor infrastructure.
Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees
PBM vs RKTO FAQ
Which stock has performed better over the past year, PBM or RKTO?
RKTO returned -61.12% over the past 12 months, compared with -96.56% for PBM (price return, excluding dividends). Past performance does not predict future results.
Are Psyence Biomedical and Rocket One in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.